Your browser doesn't support javascript.
loading
Safety and immunogenicity of COVID-19 vaccination in patients with hepatocellular carcinoma (CHESS-NMCID 2101): A multicenter prospective study.
Qi, Xiaolong; Wang, Jitao; Zhang, Qiran; Ai, Jingwen; Liu, Chuan; Li, Qianqian; Gu, Ye; Lv, Jiaojian; Huang, Yifei; Liu, Yanna; Xu, Dan; Chen, Shubo; Liu, Dengxiang; Li, Jinlong; Xiang, Huiling; Liang, Jing; Bian, Li; Zhang, Zhen; Liu, Luxiang; Zhang, Xuying; Qin, Wei; Wang, Xiaodong; Hou, Zhiyun; Zhang, Nina; Zhang, Aiguo; Zu, Hongmei; Wang, Yun; Yan, Zhaolan; Du, Xiufang; Hou, Aifang; Ji, Jiansong; Yang, Jie; Huang, Jiansheng; Zhao, Zhongwei; Zou, Shengqiang; Ji, Hailei; Ge, Guohong; Zeng, Qing-Lei; Zhang, Wenhong.
Afiliação
  • Qi X; Department of Radiology, Medical School, Center of Portal Hypertension, Zhongda Hospital, Southeast University, Nanjing, China.
  • Wang J; Department of Radiology, Medical School, Center of Portal Hypertension, Zhongda Hospital, Southeast University, Nanjing, China.
  • Zhang Q; CHESS-COVID-19 Group, Xingtai People's Hospital, Xingtai, Hebei, China.
  • Ai J; Department of Infectious Diseases, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
  • Liu C; Department of Infectious Diseases, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
  • Li Q; Department of Radiology, Medical School, Center of Portal Hypertension, Zhongda Hospital, Southeast University, Nanjing, China.
  • Gu Y; Department of Hepatology and Gastroenterology, The Third Central Hospital of Tianjin, Tianjin, China.
  • Lv J; CHESS-COVID-19 Group, The Sixth People's Hospital of Shenyang, Shenyang, Liaoning, China.
  • Huang Y; Department of Infectious Diseases, Lishui People's Hospital, Lishui, Zhejiang, China.
  • Liu Y; Department of Radiology, Medical School, Center of Portal Hypertension, Zhongda Hospital, Southeast University, Nanjing, China.
  • Xu D; Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
  • Chen S; Department of Radiology, Medical School, Center of Portal Hypertension, Zhongda Hospital, Southeast University, Nanjing, China.
  • Liu D; CHESS-COVID-19 Group, Xingtai People's Hospital, Xingtai, Hebei, China.
  • Li J; CHESS-COVID-19 Group, Xingtai People's Hospital, Xingtai, Hebei, China.
  • Xiang H; CHESS-COVID-19 Group, Xingtai People's Hospital, Xingtai, Hebei, China.
  • Liang J; Department of Hepatology and Gastroenterology, The Third Central Hospital of Tianjin, Tianjin, China.
  • Bian L; Department of Hepatology and Gastroenterology, The Third Central Hospital of Tianjin, Tianjin, China.
  • Zhang Z; CHESS-COVID-19 Group, The Sixth People's Hospital of Shenyang, Shenyang, Liaoning, China.
  • Liu L; CHESS-COVID-19 Group, The Sixth People's Hospital of Shenyang, Shenyang, Liaoning, China.
  • Zhang X; Department of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
  • Qin W; Clinal Laboratory, Lishui People's Hospital, Lishui, Zhejiang, China.
  • Wang X; Department of Gastroenterology, Baoding people's Hospital, Baoding, Heibei, China.
  • Hou Z; Department of Gastroenterology, Baoding people's Hospital, Baoding, Heibei, China.
  • Zhang N; Department of Hepatobiliary Surgery, Jincheng People's Hospital, Jincheng, Shanxi, China.
  • Zhang A; Department of Hepatobiliary Surgery, Jincheng People's Hospital, Jincheng, Shanxi, China.
  • Zu H; Department of Hepatobiliary Surgery, Jincheng People's Hospital, Jincheng, Shanxi, China.
  • Wang Y; Department of Gastroenterology, The Fourth People's Hospital of Qinghai Province, Xining, Qinghai, China.
  • Yan Z; Department of Gastroenterology, The Fourth People's Hospital of Qinghai Province, Xining, Qinghai, China.
  • Du X; Department of Gastroenterology, The Fourth People's Hospital of Qinghai Province, Xining, Qinghai, China.
  • Hou A; Department of Liver Diseases, The Third People's Hospital of Linfen City, Linfen, Shanxi, China.
  • Ji J; Department of Liver Diseases, The Third People's Hospital of Linfen City, Linfen, Shanxi, China.
  • Yang J; CHESS-COVID-19 Group, Lishui Hospital of Zhejiang University, Lishui, Zhejiang, China.
  • Huang J; CHESS-COVID-19 Group, Lishui Hospital of Zhejiang University, Lishui, Zhejiang, China.
  • Zhao Z; CHESS-COVID-19 Group, Lishui Hospital of Zhejiang University, Lishui, Zhejiang, China.
  • Zou S; CHESS-COVID-19 Group, Lishui Hospital of Zhejiang University, Lishui, Zhejiang, China.
  • Ji H; Department of Hepatology, Zhenjiang Third Hospital Affiliated to Jiangsu University, Zhenjiang, Jiangsu, China.
  • Ge G; Department of Hepatology, Zhenjiang Third Hospital Affiliated to Jiangsu University, Zhenjiang, Jiangsu, China.
  • Zeng QL; Department of Hepatology, Zhenjiang Third Hospital Affiliated to Jiangsu University, Zhenjiang, Jiangsu, China.
  • Zhang W; Department of Infectious Diseases and Hepatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
J Med Virol ; 94(11): 5553-5559, 2022 11.
Article em En | MEDLINE | ID: mdl-35811309
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Vacinas contra COVID-19 / COVID-19 / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Revista: J Med Virol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Vacinas contra COVID-19 / COVID-19 / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Revista: J Med Virol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China